Publications

Patel C, Bilgin G, Hayen A, Kirk M, Ali A, Dey A, Sargent G, Sheel M. The association between routine immunisation and COVID-19 vaccination in small Island developing states. PLoS One 2025;20:e0317327. doi: 10.1371/journal.pone.0317327. [Full text]

Koirala A, Smith K, Britton PN, Howard-Jones AR, Sintchenko V, Donnan EJ, Ulbricht E, Martinez E, Toma R, Marais BJ. Protracted tuberculosis outbreak in a pasifika diaspora in Western Sydney, Australia: the importance of community engagement. Journal of Infectious Diseases 2025;231:1532-1535. doi: 10.1093/infdis/jiae619 . [Full text]

Gebremariam AG, Genie M, Le H, Attwell K, Liu B, Regan AK, Beard FH, Macartney K, Paolucci F, Moore HC, Blyth CC. Impact of vaccine mandates and removals on COVID-19 vaccine uptake in Australia and international comparators: a study protocol. BMJ Open 2025;15:e097412. doi: 10.1136/bmjopen-2024-097412. [Full text]

Carter N, King C, Deng L, Wood N, Quinn H. Australian healthcare providers' awareness of and practices related to vaccine safety surveillance. Public Health Research & Practice 2025;35:PU24016. doi: 10.1071/PU24016. [Full text]

Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Kattan GS, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S, Kwong JC. Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study. Vaccine 2025;60:127291. doi: 10.1016/j.vaccine.2025.127291 . [Full text]

Craig AT, Lawford H, Mokoia G, Ikimau M, Fetaui P, Marqardt T, Lau CL. Integrating post-validation surveillance of lymphatic filariasis with the WHO STEPwise approach to non-communicable disease risk factor surveillance in Niue, a study protocol. PLoS ONE 2025;20:e0315625. doi: 10.1371/journal.pone.0315625. [Full text]

Burrell R, Saravanos GL, Kesson A, Leung KC, Outhred AC, Wood N, Muscatello D, Britton PN. Respiratory virus detections in children presenting to an Australian paediatric referral hospital pre-COVID-19 pandemic, January 2014 to December 2019. PLoS One 2025;20:e0313504. doi: 10.1371/journal.pone.0313504. [Full text]

Haque S, Lambert SB, Mengersen K, Barr IG, Wang L, Pongsumpun P, Li Z, Yang W, Vardoulakis S, Bambrick H, Hu W. Assessing the impact of non-pharmaceutical interventions against COVID-19 on 64 notifiable infectious diseases in Australia: a Bayesian Structural Time Series model. Journal of Infection and Public Health 2025;18:102679. doi: 10.1016/j.jiph.2025.102679 . [Full]

Lawford HL, Tukia O, Takai J, Sheridan S, Ward S, Jian H, Martin BM, 'Ofanoa R, Lau CL. Persistent lymphatic filariasis transmission seven years after validation of elimination as a public health problem: a cross-sectional study in Tonga. Lancet Regional Health Western Pacific 2025;57:101513. doi: 10.1016/j.lanwpc.2025.101513 . [Full]

McAlister SM, van den Biggelaar AH, Cooper MN, Thornton R, Richmond P, Marshall HS, Nolan T, McIntyre P, Wood N. Acellular pertussis vaccine given in the week after birth does not impair antibody responses to later childhood doses. Pediatric Infectious Disease Journal 2025;44:476-483. doi: 10.1097/INF.0000000000004764 . [Full]